LEARNING HUB
A collection of educational content about current advancements in science and technology to help promote a higher level of patient care.
A collection of educational content about current advancements in science and technology to help promote a higher level of patient care.
Learn with industry experts and thought leaders through our Ortho Science Bytes monthly podcasts, webinars, videos and additional resources — some of which provide the opportunity to earn Professional Acknowledgment for Continuing Education. You’ll gain invaluable knowledge to help your lab maximize performance and help achieve higher patient outcomes.
QuidelOrtho Corporation announced today that it has been granted a De Novo request from the U.S. Food and Drug Administration (FDA), allowing the company to market its new Sofia® 2 SARS Antigen+ FIA. The Sofia 2 SARS Antigen+ FIA is the first rapid antigen test that detects COVID-19 to be awarded FDA market clearance. The test is intended for prescription use only and can be used in point-of-care settings.
Search topics, categories and more...
Select multiple filters
Content Type
Category
Topic
Home
